Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
23.05
-0.07 (-0.30%)
At close: Mar 9, 2026, 4:00 PM EDT
23.05
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Pelthos Therapeutics Market Cap
Pelthos Therapeutics has a market cap or net worth of $76.84 million as of March 9, 2026. Its market cap has increased by 645.49% in one year.
Market Cap
76.84M
Enterprise Value
64.08M
1-Year Change
645.49%
Ranking
Category
Stock Price
$23.05
Market Cap Chart
Since February 16, 2024, Pelthos Therapeutics's market cap has increased from $27.68M to $76.84M, an increase of 177.58%. That is a compound annual growth rate of 64.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 74.81M | -21.82% |
| Dec 31, 2025 | 95.69M | 2,376.40% |
| Dec 31, 2024 | 3.86M | -86.04% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seres Therapeutics | 82.59M |
| Pliant Therapeutics | 81.73M |
| Champions Oncology | 81.51M |
| aTyr Pharma | 80.79M |
| PolyPid | 79.96M |
| AN2 Therapeutics | 78.10M |
| Coeptis Therapeutics Holdings | 74.92M |
| Adicet Bio | 73.67M |